scholarly journals HMG-CoA Reductase Inhibitor, Simvastatin Improves Reverse Cholesterol Transport in Type 2 Diabetic Patients with Hyperlipidemia

2008 ◽  
Vol 15 (1) ◽  
pp. 20-25 ◽  
Author(s):  
Jing-Zhi Guan ◽  
Naoki Tamasawa ◽  
Hiroshi Murakami ◽  
Jun Matsui ◽  
Jutaro Tanabe ◽  
...  
Keyword(s):  
Reverse Cholesterol Transport ◽  
Reductase Inhibitor ◽  
Diabetic Patients ◽  
Cholesterol Transport ◽  
Type 2 Diabetic Patients ◽  
Hmg Coa Reductase ◽  
Hmg Coa Reductase Inhibitor ◽  
Coa Reductase ◽  
Type 2 Diabetic

Insulin-induced glucose control improves HDL cholesterol levels but not reverse cholesterol transport in type 2 diabetic patients

2014 ◽  
Vol 235 (2) ◽  
pp. 415-417 ◽  
Author(s):  
Gian Paolo Fadini ◽  
Elisabetta Iori ◽  
Maria Cristina Marescotti ◽  
Saula Vigili de Kreutzenberg ◽  
Angelo Avogaro
Keyword(s):  
Glucose Control ◽  
Reverse Cholesterol Transport ◽  
Hdl Cholesterol ◽  
Diabetic Patients ◽  
Cholesterol Transport ◽  
Type 2 Diabetic Patients ◽  
Cholesterol Levels ◽  
Type 2 Diabetic

Postprandial reverse cholesterol transport in type 2 diabetic patients: effect of a lipid lowering treatment

2000 ◽  
Vol 153 (2) ◽  
pp. 453-460 ◽  
Author(s):  
Delphine Autran ◽  
Nebil Attia ◽  
Marek Dedecjus ◽  
Vincent Durlach ◽  
Anik Girard-Globa
Keyword(s):  
Reverse Cholesterol Transport ◽  
Lipid Lowering ◽  
Diabetic Patients ◽  
Cholesterol Transport ◽  
Type 2 Diabetic Patients ◽  
Type 2 Diabetic
Sign in / Sign up

Export Citation Format

Share Document